Clinical Trial Update: Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating trastuzumab, cyclophosphamide, and an allogeneic GM-CSF-secreting breast tumor vaccine in HER-2/neu-overexpressing metastatic breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Allogeneic GM-CSF-secreting breast tumor vaccine
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2020-04-13